Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
23,920,591
-
Share change
-
-634,513
-
Total reported value
-
$355,117,215
-
Price per share
-
$14.84
-
Number of holders
-
105
-
Value change
-
-$14,172,545
-
Number of buys
-
46
-
Number of sells
-
50
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2020
As of 31 Mar 2020,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,920,591 shares.
The largest 10 holders included
BlackRock Inc., FEDERATED HERMES, INC., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Invesco Ltd., RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and Voya Investment Management LLC.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.